A randomized controlled trial of azithromycin versus doxycycline for the treatment of rectal chlamydia in men who have SEX with men.
Ended Awarded Last action
- Contract number
- HHSN27200013
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $927,885
Award facts
- Contract value 100% obligated
- $927,885.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$48,745 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $976,630 |
About this award
This $927,885.48 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health to the University of Alabama at Birmingham to conduct a randomized controlled trial comparing the effectiveness of azithromycin versus doxycycline for treating rectal chlamydia in men who have sex with men. The contract has no set-aside designation. The University of Alabama at Birmingham has served as the prime contractor, with sub-awards issued to Family Health International (FHI 360) to serve as the Operations Coordinating Center and to the University of Washington and Fenway Community Health Center to support protocol development, implementation, and analysis. This effort is part of the Sexually Transmitted Infections Clinical Trials Group and aligns with the National Institute of Allergy and Infectious Diseases' mission to conduct research to better understand, treat, and prevent infectious diseases.
Quick answers
Who was awarded contract HHSN27200013?
HHSN27200013 was awarded to University Of Alabama At Birmingham by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2017.
How much is contract HHSN27200013 worth?
The government has obligated $927,885 on HHSN27200013.
Is contract HHSN27200013 an order under another contract?
Yes. HHSN27200013 is a delivery order under HHSN272201300012I, an indefinite delivery contract.
Was contract HHSN27200013 competed?
The extent of competition for HHSN27200013 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award